PA Capital’s Thermo Fisher Scientific TMO Stock Holding History

PA Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.12M	Sell	2,527 -310	-11%	-$128K	0.78%	39
2020 Q2	$1.03M	Sell	2,837 -1,227	-30%	-$411K	0.74%	41
2020 Q1	$1.15M	Buy	4,064 +285	+8%	+$89.9K	1.02%	26
2019 Q4	$1.23M	Sell	3,779 -409	-10%	-$124K	1.09%	24
2019 Q3	$1.22M	Sell	4,188 -1,402	-25%	-$401K	1.2%	21
2019 Q2	$1.64M	Buy	5,590 +169	+3%	+$46.5K	1.49%	16
2019 Q1	$1.48M	Sell	5,421 -986	-15%	-$245K	1.32%	19
2018 Q4	$1.43M	Buy	+6,407	New	+$1.5M	1.52%	15

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PA Capital's TMO Position: Q3 2020 in Review

PA Capital reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q3 2020, selling an estimated $128K and leaving 2,527 shares worth $1.12M. The position accounts for 0.78% of the portfolio, ranked #39.

PA Capital first reported a position in TMO in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.64M in Q2 2019. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

PA Capital held 2,527 shares of Thermo Fisher Scientific worth $1.12M as of Q3 2020.
PA Capital sold 310 Thermo Fisher Scientific shares in Q3 2020, an estimated $128K.
Thermo Fisher Scientific made up 0.78% of PA Capital's portfolio in Q3 2020, its #39 holding.
PA Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 8 quarters since.
PA Capital's Thermo Fisher Scientific position peaked at $1.64M in Q2 2019.
1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.